Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES)

Location:

Rochester, Minn.

Trial status:
Open for Enrollment
Why is this study being done?

Purposive sample: patients are not randomly selected, that is, he or she must meet certain inclusion criteria in order to qualify as a potential study participant.

Who is eligible to participate?

Inclusion Criteria: - Children age 6 to 16 (inclusive) with anxiety, depression, or obsessive-compulsive disorder, receiving treatment in outpatient setting, and who are prescribed a new prescription for sertraline to treat one of the above study-qualifying disorders or beginning psychotherapy for same. Exclusion Criteria: - Psychotic at study entry - Diagnosis of bipolar disorder - Diagnosis of schizoaffective or schizophrenia - Anorexia - Bulimia or eating disorder not otherwise specified (NOS) - Autism - Pervasive developmental disorder - High risk of suicide within 2 weeks of initiating study treatment - Significant mental retardation

Last updated:
4/11/2014
NCT ID:
NCT01302080
IRB Number:
12-004297